192 related articles for article (PubMed ID: 15502011)
21. CCAAT/enhancer-binding proteins (C/EBPs) regulate the basal and cAMP-induced transcription of the human 11beta-hydroxysteroid dehydrogenase encoding gene in adipose cells.
Gout J; Tirard J; Thévenon C; Riou JP; Bégeot M; Naville D
Biochimie; 2006 Sep; 88(9):1115-24. PubMed ID: 16837116
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone regulates the expression of hepatocyte nuclear factor-3 gamma and other liver-enriched transcription factors in the bovine liver.
Eleswarapu S; Jiang H
J Endocrinol; 2005 Jan; 184(1):95-105. PubMed ID: 15642787
[TBL] [Abstract][Full Text] [Related]
23. Regulation of rat alcohol dehydrogenase by cyclic AMP in primary hepatocyte culture.
Potter JJ; MacDougald OA; Mezey E
Arch Biochem Biophys; 1995 Aug; 321(2):329-35. PubMed ID: 7646058
[TBL] [Abstract][Full Text] [Related]
24. Effect of the CCAAT/enhancer binding protein on expression of the gene for chicken malic enzyme.
Chung SS; MacPhee KG; Goodridge AG
Arch Biochem Biophys; 1999 Apr; 364(1):30-41. PubMed ID: 10087162
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the rat class I alcohol dehydrogenase gene by growth hormone.
Potter JJ; Yang VW; Mezey E
Biochem Biophys Res Commun; 1993 Mar; 191(3):1040-5. PubMed ID: 8466483
[TBL] [Abstract][Full Text] [Related]
26. Induction of human sulfotransferase 1A3 (SULT1A3) by glucocorticoids.
Bian HS; Ngo SY; Tan W; Wong CH; Boelsterli UA; Tan TM
Life Sci; 2007 Dec; 81(25-26):1659-67. PubMed ID: 17963788
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoids regulate the CCSP and CYP2B1 promoters via C/EBPbeta and delta in lung cells.
Berg T; Cassel TN; Schwarze PE; Nord M
Biochem Biophys Res Commun; 2002 May; 293(3):907-12. PubMed ID: 12051744
[TBL] [Abstract][Full Text] [Related]
28. Involvement of CCAAT/enhancer binding protein-beta (C/EBPbeta) in epigenetic regulation of mouse methionine adenosyltransferase 1A gene expression.
Ikeda R; Nishida T; Watanabe F; Shimizu-Saito K; Asahina K; Horikawa S; Teraoka H
Int J Biochem Cell Biol; 2008; 40(9):1956-69. PubMed ID: 18346930
[TBL] [Abstract][Full Text] [Related]
29. The role of CCAAT/enhancer-binding protein beta in the transcriptional regulation of COX-2 in human amnion.
Lee YS; Terzidou V; Lindstrom T; Johnson M; Bennett PR
Mol Hum Reprod; 2005 Dec; 11(12):853-8. PubMed ID: 16399783
[TBL] [Abstract][Full Text] [Related]
30. Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes.
Duanmu Z; Locke D; Smigelski J; Wu W; Dahn MS; Falany CN; Kocarek TA; Runge-Morris M
Drug Metab Dispos; 2002 Sep; 30(9):997-1004. PubMed ID: 12167565
[TBL] [Abstract][Full Text] [Related]
31. Trichostatin A, a critical factor in maintaining the functional differentiation of primary cultured rat hepatocytes.
Henkens T; Papeleu P; Elaut G; Vinken M; Rogiers V; Vanhaecke T
Toxicol Appl Pharmacol; 2007 Jan; 218(1):64-71. PubMed ID: 17125810
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
Chew CH; Chew GS; Najimudin N; Tengku-Muhammad TS
Int J Biochem Cell Biol; 2007; 39(10):1975-86. PubMed ID: 17616429
[TBL] [Abstract][Full Text] [Related]
33. Expression of CCAAT/enhancer binding protein family genes in monolayer and sandwich culture of hepatocytes: induction of stress-inducible GADD153.
Wilkinson RC; Dickson AJ
Biochem Biophys Res Commun; 2001 Dec; 289(5):942-9. PubMed ID: 11741281
[TBL] [Abstract][Full Text] [Related]
34. Structural requirements of the glucocorticoid-response unit of the carbamoyl-phosphate synthase gene.
Schoneveld OJ; Gaemers IC; Das AT; Hoogenkamp M; Renes J; Ruijter JM; Lamers WH
Biochem J; 2004 Sep; 382(Pt 2):463-70. PubMed ID: 15196051
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte-specific interplay of transcription factors at the far-upstream enhancer of the carbamoylphosphate synthetase gene upon glucocorticoid induction.
Hoogenkamp M; Gaemers IC; Schoneveld OJ; Das AT; Grange T; Lamers WH
FEBS J; 2007 Jan; 274(1):37-45. PubMed ID: 17140418
[TBL] [Abstract][Full Text] [Related]
36. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
37. Regulation of sulfotransferases by xenobiotic receptors.
Runge-Morris M; Kocarek TA
Curr Drug Metab; 2005 Aug; 6(4):299-307. PubMed ID: 16101570
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional regulation of human CYP2A13 expression in the respiratory tract by CCAAT/enhancer binding protein and epigenetic modulation.
Ling G; Wei Y; Ding X
Mol Pharmacol; 2007 Mar; 71(3):807-16. PubMed ID: 17148654
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effect of dexamethasone and beta-adrenergic receptor agonists on the nerve growth factor gene transcription.
Colangelo AM; Mallei A; Johnson PF; Mocchetti I
Brain Res Mol Brain Res; 2004 May; 124(2):97-104. PubMed ID: 15135217
[TBL] [Abstract][Full Text] [Related]
40. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
